Barricks, Nevada

Barrick's Nevada Peace Dividend: Analysts Split on Whether the Fourmile Trade Was Worth It

Published on 08/17/2026 at 16:22 | Redaktion boerse-global.de

Barrick's $1.95B Newmont settlement and Fourmile dilution divide analysts, with targets ranging from $54 to $70 amid strong Q2 output.

Barrick-Newmont Nevada Deal Sparks Analyst Split on Price Targets
Barrick Mining Illustration mit AI erstellt übermittelt durch boerse-global.de

The settlement that ended Barrick's long-running feud with Newmont over their Nevada joint venture was always going to be a double-edged sword. On one side sits a $1.95 billion cash payment and a clear runway toward a North American listing. On the other, the cost of folding the Fourmile project into the shared complex — a dilution of future earnings that has left the analyst community visibly divided.

That split was on full display this week as four research houses revised their price targets in opposing directions. National Bank Financial's Shane Nagle led the bulls, reaffirming an "Outperform" rating on Wednesday while lifting his target from $67.50 to $70.00. His reasoning: the Newmont payment, due within thirty days of the August 10 agreement, plus a revised valuation basis built on expected 2027 EBITDA.

Barclays took a more measured step, raising its target from C$55.00 to C$58.00 on Thursday. But the bears were equally vocal. TD Cowen's Steven Green trimmed his target from $61 to $59 on Tuesday, keeping a "Buy" rating but flagging that the Fourmile contribution to the Nevada joint venture dilutes net asset value by 4 percent. BofA Securities went further, cutting its target from $56 to $54 the same day after slashing its valuation of Fourmile's contribution to Barrick by $2.8 billion — a move that knocked the estimated total NAV down 3.5 percent to $43.05 per share.

A $4 Billion Deal With Two Very Different Readings

The disagreement boils down to how one interprets the transaction struck just over a week ago. Barrick is contributing Fourmile to Nevada Gold Mines, while Newmont brings in the Mike and Fiberline projects. The package carries a combined price tag of roughly $4 billion.

Advertisement

For the optimists, the deal delivers cash, strategic clarity, and — crucially — Newmont's consent to Barrick's planned US listing of its North American operations. Management wants the spin-off completed by the end of 2026, subject to market conditions and regulatory approvals. Mark Hill is slated to lead the new entity, while Barrick searches for a CEO to run the remaining international business. The structure, the thinking goes, could unlock a valuation premium that the integrated company has never commanded.

The skeptics see it differently. The vend-in structure means Barrick is effectively giving up a slice of future Fourmile output in exchange for near-term liquidity and peace. That trade-off, they argue, is not obviously value-accretive — hence the NAV haircuts and the cautious price target revisions.

The Operating Picture: Strong Output, Rising Costs

Beneath the analyst jockeying sits a company that delivered a robust second quarter. Gold production of 796,000 ounces blew past the guided range of 730,000 to 770,000 ounces. Net income jumped 50 percent to $1.22 billion, while adjusted earnings per share climbed 74 percent to $0.82. Revenue reached $5.29 billion, with operating cash flow of $1.70 billion — evidence that the elevated gold price is flowing through to the bottom line.

Net liquidity swung from $73 million to $1.2 billion, backed by an undrawn $3 billion credit facility. Shareholders also benefited: Barrick repurchased $1.209 billion worth of stock during the quarter under its $3 billion buyback program, and a quarterly dividend of $0.175 per share is payable on September 15.

The cost side, however, tells a less flattering story. All-in sustaining costs rose 11 percent year over year to $1,866 per ounce, while cash costs climbed 20 percent to $1,993. Lower ore grades at Carlin, Cortez, and North Mara, along with higher fuel expenses tied to the Iran-Israel conflict and increased royalties, drove the increase. The full-year cost-of-sales guidance of $1,870 to $2,070 per ounce remains intact, but the margin between the gold rally and operational cost pressure is visibly narrowing.

Management has also trimmed capital expenditure guidance to $3.8–$4.2 billion, largely due to reduced spending at Lumwana and Reko Diq. The latter isn't scheduled to begin plant construction until 2026, while Lumwana's first copper is expected in early 2028 — a timeline that suggests discipline rather than distress.

A Market Waiting for Clarity

The share price, meanwhile, has been treading water. Friday's close of C$57.80 marked a 1.3 percent gain on the day, with the stock up 18 percent over the past month. Yet it remains 22 percent below its 52-week high of C$74.00, reached in late January, and is down 3.3 percent year to date. The gap between the recent high and current levels — the stock also sits 75 percent above its yearly low of C$33.02 — underscores how much of the gold rally was already priced in before the Nevada dispute was resolved.

The divergent analyst reactions suggest the consolidation phase may persist until the market reaches a consensus on what the Nevada complex is actually worth under the new ownership structure. The strategic logic of ending a years-long dispute and clearing the path for a listing is hard to argue with. Whether the price paid for that clarity — a permanent claim on Fourmile's future output — was the right one remains very much an open question.

Advertisement

While the market digests the implications of this restructuring, one thing remains certain: managing operational risk is central to protecting shareholder value. The same discipline that guides prudent capital allocation applies to workplace safety — where a single overlooked hazard can derail operations and invite regulatory scrutiny. A free toolkit with 41 ready-to-use templates and checklists helps you document risks systematically and stay compliant. Download the free Risk Assessment Toolkit

Disclaimer...

en | CA0679011084 | BARRICKS | boerse | 69959570 |